[开发一种输液方案,以避免成人重症监护病人的不兼容性]
D Meyn1,2, T Hesener3, L Kreysing4
1Apotheke des Klinikum Kassel, Klinikum Kassel, Mönchebergstraße 41-43, 34125, Kassel, Deutschland. damaris.meyn@gnh.net.
Medizinische Klinik, Intensivmedizin und Notfallmedizin
|January 13, 2026
概括
这项研究开发了一种针对重症监护病房的输液方案,以防止Y位处方不兼容. 新方案通过考虑成年重症监护患者的药物组合和度,确保更安全的药物输送.
科学领域:
- 关键护理医学 关键护理医学
- 制药科学 制药科学
- 临床药房 临床药房 临床药房
背景情况:
- 在ICU中,同时使用多种IV溶液 (Y-site) 是常见的.
- 物理化学不兼容性可能会损害药物的疗效和患者的安全.
- 缺乏标准化的输液方案有助于Y位处方的风险.
研究的目的:
- 开发和制定一个基于证据的输液方案.
- 为了最大限度地减少成年重症监护患者的Y部位不相容.
- 通过结构化方法优化药物输送安全性.
主要方法:
- 使用ADKA-DIVI标准进行了全面的文献搜索.
- 使用像STABILIS,Kingguide和Trissel's这样的数据库评估药物兼容性.
- 对于经常使用的组合而缺乏兼容性信息的编制稳定性数据.
- 开发了一个4流明的中央静脉导管 (CVC) 输液方案.
主要成果:
- 在Y位处方中确定了潜在的物理化学不兼容性.
- 编制了34种常见活性成分的兼容性和稳定性数据.
- 制定了一种4流明CVC输液方案,旨在避免不兼容性.
- 为临床医生提供了一个实用的工具来管理复杂的输液.
结论:
- 开发的输液方案有效地解决了ICU中的Y-site管理挑战.
- 实施这种疗法可以提高药物治疗的安全性和有效性.
- 该战略支持在重症监护机构的基于证据的实践.
相关概念视频
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
227
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
227
Drug Dosing: Infants and Children
248
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
231
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
231
One-Compartment Model: IV Infusion
487
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
487
Pharmacokinetics in Pediatric Patients: Drug Excretion
207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207
Dosage Regimens: Designs and Approaches
258
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
258


